INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

CHARLES SCHWAB INVESTMENT MANAGEMENT INC's Holding History (CIK: 0000884546)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 45,182 Value ($000) $181 Avg Close — Range —
Q1 2025
Shares 122,290 Value ($000) $111 Avg Close — Range —
Q4 2024
Shares 143,158 Value ($000) $397 Avg Close — Range —
Q3 2024
Shares 143,158 Value ($000) $749 Avg Close — Range —
Q2 2024
Shares 143,158 Value ($000) $638 Avg Close — Range —
Q1 2024
Shares 126,535 Value ($000) $969 Avg Close — Range —
Q4 2023
Shares 121,650 Value ($000) $518 Avg Close — Range —
Q3 2023
Shares 93,995 Value ($000) $395 Avg Close — Range —
Q2 2023
Shares 88,257 Value ($000) $492 Avg Close — Range —
Q1 2023
Shares 16,549 Value ($000) $95 Avg Close — Range —
Q4 2022
Shares 16,549 Value ($000) $17 Avg Close — Range —
Q3 2022
Shares 16,549 Value ($000) $45 Avg Close — Range —
Q2 2022
Shares 16,549 Value ($000) $79 Avg Close — Range —
Q1 2022
Shares 30,497 Value ($000) $125 Avg Close — Range —
Q4 2021
Shares 36,427 Value ($000) $249 Avg Close — Range —
Q3 2021
Shares 36,427 Value ($000) $423 Avg Close — Range —
Q2 2021
Shares 61,917 Value ($000) $1,056 Avg Close — Range —
Q1 2021
Shares 59,495 Value ($000) $1,179 Avg Close — Range —
Q4 2020
Shares 49,045 Value ($000) $1,013 Avg Close — Range —
Q3 2020
Shares 48,334 Value ($000) $1,271 Avg Close — Range —